A Quiet Revolution in Dermatology: How Microcurrents Are Changing the Approach to Treating Vitiligo
Microcurrent Therapy for Vitiligo: A Scientific Review of Innovative Methods Vitiligo is a challenge medicine has been tackling for decades. […]
tacrolimus
Segmental vs Nonsegmental Vitiligo: Clinical Features, Prognosis & Management
Key Takeaways Segmental vitiligo (SV): early onset, unilateral/dermatomal distribution, rapid stabilization; best surgical candidate once stable. Nonsegmental vitiligo (NSV): bilateral/symmetric
Combination Algorithms in Vitiligo: NB-UVB/Excimer with Topicals (Steroids, Calcineurin Inhibitors, JAK) by Zone
Key Takeaways Backbone: NB-UVB 311 nm for generalized disease; excimer 308 nm for focal patches, rims, and acral borders. Face/folds: tacrolimus (±
Relapse & Maintenance in Vitiligo: TRM Biology, Risk Stratification, and Practical Maintenance Schedules
Key Takeaways Why relapse? Persistent tissue-resident memory T cells (TRM) linger in previously affected skin and can reignite depigmentation after
Pediatric Vitiligo: Therapy, Safety, and Phototherapy Protocols
Key Takeaways Face/neck first-line: topical calcineurin inhibitors (tacrolimus 0.03–0.1%) are preferred to avoid steroid atrophy. Generalized disease: NB-UVB 311 nm 2–3×/wk
NB-UVB 311 nm in Vitiligo: Dosing Protocols, Cohort Outcomes, and Practical Tips
Key Takeaways Backbone therapy for generalized/nonsegmental vitiligo; best responses on face/neck, slower on acral sites. Start low, escalate by 10–20%
Vitiligo Combination Algorithms: NB-UVB / Excimer 308 + Topicals (Steroids, Calcineurin Inhibitors, JAK) by Site
Key Takeaways Face/neck: NB-UVB or excimer + tacrolimus 0.1% is first-line; consider label-eligible topical JAK for added speed in limited
Vitiligo Relapse & Maintenance: TRM Biology and Practical Therapy Schemes
Key Takeaways Relapse is driven by tissue-resident memory T cells (TRM) and the IFN-γ–CXCL9/10 chemokine loop that re-recruits cytotoxic T
Excimer 308 nm in Vitiligo: Focal Therapy for Face/Neck and Acral Margins
Key Takeaways Targeted 308 nm is effective for limited facial/neck lesions and expanding edges of patches. Acral sites (hands/feet) respond slower;